Eurofins: acquires Synlab's activities in Spain
(CercleFinance.com) - Eurofins Scientific announces that it has signed an agreement with Synlab to acquire its clinical diagnostics activities in Spain, a transaction subject to customary conditions, including regulatory approvals, and expected to be completed in 2025.
The activities in question represented sales of around E140m in 2023, and will make Eurofins the leading clinical diagnostics operator in Spain, able to serve public and private customers in all regions of the country.
The combined company will have a highly specialized workforce of more than 2,000 employees and a first-class portfolio of laboratory tests, based on the latest scientific and technological medical advances, it says.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The activities in question represented sales of around E140m in 2023, and will make Eurofins the leading clinical diagnostics operator in Spain, able to serve public and private customers in all regions of the country.
The combined company will have a highly specialized workforce of more than 2,000 employees and a first-class portfolio of laboratory tests, based on the latest scientific and technological medical advances, it says.
Copyright (c) 2024 CercleFinance.com. All rights reserved.